PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $517,000 | +136.1% | 139,113 | +84.3% | 0.00% | +200.0% |
| Q4 2018 | $219,000 | -59.0% | 75,499 | -62.8% | 0.00% | -66.7% |
| Q3 2018 | $534,000 | +12.7% | 202,826 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $474,000 | +13.4% | 202,826 | +42.7% | 0.00% | 0.0% |
| Q1 2018 | $418,000 | +7.2% | 142,097 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $390,000 | -18.9% | 142,097 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $481,000 | +37.0% | 142,097 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $351,000 | +118.0% | 142,097 | +99.9% | 0.00% | +200.0% |
| Q1 2017 | $161,000 | +6.6% | 71,074 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $151,000 | -36.6% | 71,074 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $238,000 | +6.7% | 71,074 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $223,000 | -19.2% | 71,074 | +80.7% | 0.00% | -33.3% |
| Q1 2015 | $276,000 | -9.2% | 39,323 | -0.3% | 0.00% | -25.0% |
| Q4 2014 | $304,000 | +3.4% | 39,452 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $294,000 | – | 39,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |